Steven Goldby

Steven Goldby joined Venrock in 2007 after spending nine years as CEO of Venrock-backed materials science company, Symyx Technologies, where he is currently Executive Chairman. Mr. Goldby has served as the CEO of MDL Information Systems, a leading scientific information company, before its sale to Reed Elsevier. Prior to MDL, he held various management positions at Alza Corporation (acquired by Johnson and Johnson), including President of Alza Pharmaceuticals. Mr. Goldby was also President of Dynapol, a specialty chemical company and is a registered patent attorney. Mr. Goldby serves on the board of Intermolecular, Inc. Previously, he served on the boards of Vitae Pharmaceuticals (a Venrock-backed company), Ilypsa (acquired by Amgen), Affymax (acquired by GSK), Scios (acquired by Johnson and Johnson), PeopleSoft (acquired by Oracle), Aspect Development (acquired by Itwo), TGV (acquired by Cisco), One Touch Systems (acquired by Apollo Group), Scientific Software (acquired by Agilent). Mr. Goldby is director of Orecon Ltd and Sunesis Pharmaceuticals and Chairman of Nanosys Inc.